EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancer
Non-small cell lung cancer (NSCLC), caused by various mutations in a spectrum of cancer driver genes, may have distinct pathological characteristics and drug responses. Extensive genetic screening and pathological characterization is required for the design of customized therapies to improve patient...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
D.A. Spandidos
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812214/ |